Seqirus Quadrivalent Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Seqirus Quadrivalent Influenza Vaccine, covering 2019-01-23 to 2019-01-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. [Phase 3]